Physician
Orthovirginia, INC.
Orthovirginia, INC. was paid $23.77M by Medicaid between Jan 2018 and Dec 2024, across 93 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.
33Billing provider infoORTHOVIRGINIA, INC.
NORTH CHESTERFIELD, VA 23225
NORTH CHESTERFIELD, VA 23225
33aNPI1265470645assigned 06/04/2006
33bProvider typeOrthopaedic Surgery Physician
28Total paid$23.77M
24GClaims526,180
24DCodes billed93
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Orthopaedic Surgery Physician providers in Virginia
Rank by total paid#1 of 79
Median peer was paid$6K
This provider vs. median3,920×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,727 | $637K | |
| 2019 | 57,633 | $2.11M | |
| 2020 | 62,809 | $2.75M | |
| 2021 | 83,391 | $3.64M | |
| 2022 | 92,595 | $4.39M | |
| 2023 | 105,686 | $5.20M | |
| 2024incomplete | 100,339 | $5.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 75,501 | 69,541 | $5.26M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 18% | 86,732 | 77,953 | $4.19M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13% | 32,412 | 30,357 | $3.19M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 8.1% | 28,083 | 26,354 | $1.92M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 7.5% | 68,761 | 25,804 | $1.79M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 6.3% | 38,400 | 16,328 | $1.49M |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3.7% | 27,774 | 11,063 | $883K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.3% | 36,638 | 14,733 | $547K |
| 97161 | 2.1% | 8,190 | 7,783 | $502K | |
| 20610 | 1.6% | 9,775 | 8,635 | $382K | |
| 95886 | 1.4% | 3,384 | 3,121 | $338K | |
| 64483 | 1.2% | 1,936 | 1,822 | $293K |
81 more codes
| 73630 | 1.2% | 12,463 | $283K | |
| 73610 | <1% | 7,958 | $207K | |
| 97162 | <1% | 3,272 | $182K | |
| L3808 | Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment | <1% | 636 | $180K |
| 73110 | <1% | 5,819 | $173K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 5,482 | $173K |
| 72110 | <1% | 4,650 | $162K | |
| 73564 | <1% | 4,383 | $139K | |
| 73562 | <1% | 5,106 | $136K | |
| 97165 | <1% | 1,947 | $127K | |
| L4361 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf | <1% | 515 | $119K |
| 72100 | <1% | 3,565 | $98K | |
| 95911 | <1% | 616 | $93K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,303 | $80K |
| 73030 | <1% | 3,638 | $80K | |
| 73130 | <1% | 2,907 | $79K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 11,240 | $61K |
| 11721 | <1% | 3,336 | $56K | |
| A4590 | Special casting material (e.g., fiberglass) | <1% | 1,821 | $45K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 2,475 | $37K |
| L3906 | Wrist hand orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment | <1% | 119 | $37K |
| 72040 | <1% | 1,240 | $33K | |
| 11750 | <1% | 331 | $31K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 3,984 | $26K |
| 64484 | <1% | 341 | $23K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 231 | $23K |
| 95910 | <1% | 174 | $21K | |
| 73140 | <1% | 721 | $21K | |
| L3913 | Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment | <1% | 83 | $19K |
| 73080 | <1% | 706 | $18K | |
| L3933 | Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment | <1% | 97 | $15K |
| 20611 | <1% | 244 | $15K | |
| 73560 | <1% | 794 | $15K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 275 | $13K |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 987 | $13K |
| 29075 | <1% | 174 | $12K | |
| 73100 | <1% | 460 | $12K | |
| 97163 | <1% | 206 | $11K | |
| 73502 | <1% | 342 | $10K | |
| 72050 | <1% | 262 | $10K | |
| 11056 | <1% | 297 | $10K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 124 | $7K |
| 20551 | <1% | 204 | $6K | |
| 27096 | <1% | 38 | $6K | |
| 99152 | <1% | 833 | $5K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,155 | $5K |
| 96132 | <1% | 56 | $5K | |
| 11055 | <1% | 104 | $4K | |
| 20550 | <1% | 108 | $4K | |
| 64493 | <1% | 29 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,459 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 267 | $3K |
| 20552 | <1% | 68 | $3K | |
| 73501 | <1% | 149 | $3K | |
| 62321 | <1% | 13 | $3K | |
| 97166 | <1% | 40 | $2K | |
| 29125 | <1% | 48 | $2K | |
| 73590 | <1% | 69 | $2K | |
| L1902 | Ankle orthosis, ankle gauntlet or similar, with or without joints, prefabricated, off-the-shelf | <1% | 30 | $1K |
| 73600 | <1% | 63 | $1K | |
| 99000 | <1% | 954 | $1K | |
| 73090 | <1% | 56 | $1K | |
| 95885 | <1% | 16 | $796.59 | |
| 73620 | <1% | 52 | $766.49 | |
| 72082 | <1% | 14 | $741.85 | |
| 64494 | <1% | 18 | $733.45 | |
| 77077 | <1% | 13 | $529.77 | |
| 62323 | <1% | 16 | $514.91 | |
| 72081 | <1% | 15 | $472.10 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 889 | $455.15 |
| 72170 | <1% | 29 | $431.93 | |
| 96146 | <1% | 168 | $329.96 | |
| 73120 | <1% | 14 | $324.49 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,329 | $212.18 |
| 97010 | <1% | 36 | $28.00 | |
| 1123F | 0% | 23 | $0.00 | |
| 1124F | 0% | 743 | $0.00 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 57 | $0.00 |
| G8984 | Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 16 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 61 | $0.00 |
| G8985 | Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 18 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFERRELL, JUSTIN (EXECUTIVE DIRECTOR)